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Introduction
Multiple sclerosis (MS) is a chronic disease affecting 
young adults, particularly women in childbearing 
age. In Portugal, the estimated prevalence of MS is 
46.3/100.000 [1,2]. In the past, women with MS 
were discouraged from becoming pregnant due to 
the possible negative effect of pregnancy on the 
course of the disease. In addition, the influence of 
the disease on the course and outcome of pregnancy 
(and vice versa) was also unknown for many years.
The Pregnancy in Multiple Sclerosis (PRIMS) 
study was the first prospective study to demon-
strate a reduction in the relapse rate during preg-
nancy, especially in the third trimester, and a sub-
sequent increase in the first three months after de-
livery [3]. Moreover, it showed that an increased 
relapse rate in the pre-pregnancy year and during 
pregnancy and a high Kurtzke’s Disability Status 
Scale score at the beginning of pregnancy were 
positively related to the occurrence of a relapse 
in the post-partum period [3]. Other retrospective 
and prospective studies helped to reach the con-
sensus that the relapse rate actually declines dur-
ing pregnancy and increases in the first three 
months post-partum without greater future dis-
ability [4-6]. Even though the most important risk 
factor for a relapse in the post-partum period is the 
number of relapses before and during pregnancy, 
additional risk factors, modifiable or not, need yet 
to be determined. Besides, as the relapse rate prior 
to pregnancy is nowadays decreased due to the use 
of immunomodulatory drugs, the relapse rate prior 
to pregnancy may not represent the activity of the 
disease [7].
MS treatment is based on immunomodulatory 
and immunosuppressive drugs, which have a high 
patient’s adequate adherence [8]. However, evi-
dence of the safety of these drugs during pregnancy 
is still lacking [9]. The reduction in relapses during 
pregnancy is about the same obtained with the ex-
isting drugs. Although women stop MS therapy 
during pregnancy, the disease is not expected to 
worsen [10].
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Introduction. Multiple sclerosis (MS) is a disabling disease occurring mainly in women of childbearing age. MS may interfere 
with family planning and motherhood decision. 
Aim. To study the influence of MS diagnosis and course of the disease on motherhood decision. 
Patients and methods. The cohort of 35 to 45-year-old female patients diagnosed with MS for at least ten years was 
selected from six Portuguese MS centers. A structured questionnaire was applied to all patients in consecutive consultation 
days. Clinical records were reviewed to characterize and collect information about the disease and pregnancies. 
Results. One hundred women were included; mean age at MS diagnosis was 26.3 ± 5.0 years; 90% of the participants 
presented with a relapsing-remitting MS; 57% had no pregnancies after the diagnosis. MS type and number of relapses 
were not significantly different between women with or without pregnancies after the diagnosis (p = 0.39 and p = 0.50, 
respectively). Seventy-seven percent of the patients did not have the intended number of pregnancies. Main reasons given 
were fear of future disability and the possibility of having relapses. Forty-three women considered that pregnancy might 
worsen MS. 
Conclusion. In our population, motherhood choice was unrelated to the MS type and the number of relapses. However, a 
relevant number of women had fewer pregnancies than those intended before MS diagnosis and believed that pregnancy 
could worsen the disease. An effort to better inform the patients should be made to minimize the impact of MS diagnosis 
on motherhood decision.
Key words. Motherhood decision. Multiple sclerosis. Planned pregnancy. Portuguese. Pregnancy. Reproduction.
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Concerning obstetric and neonatal characteris-
tics, no major complications have been described 
in women with MS [9,11]. In delivery there were 
reports of an increase of cesarean labor and in-
strumental labor (caused by a prolonged second 
stage) but without further complications. In neo-
nates although a higher percentage of low birth 
weight was observed no major differences were 
found in Apgar scores, birth defects or birth mor-
tality [9]. 
As a chronic and disabling disease, MS might 
have an impact on family planning, especially with 
respect to the motherhood decision of female pa-
tients. However, the literature about this topic is 
scarce. Few descriptive studies tried to identify the 
main concerns of women with MS when consider-
ing motherhood decision. Uncertainty about the 
course of MS, the effect of pregnancy on the dis-
ease course and conflicting advice were some of the 
concerns identified [12-14]. A recently published 
Canadian study concluded that the most common 
MS-related reasons for not becoming pregnant 
were: symptoms interfering with parenting, fear of 
burdening the partner or fear of children inheriting 
MS [15]. There was also evidence that women 
needed more information about the effect of MS on 
pregnancy and the effect of pregnancy on the pro-
gression of MS [13]. 
The aim of this study was to document the influ-
ence of MS diagnosis and course of the disease on 
motherhood decision in a population of Portuguese 
female patients with MS, which is an issue scarcely 
addressed in the literature. 
Patients and methods
We conducted an observational multicentre study 
in women with MS, involving six hospital MS cen-
ters that cover a large geographic area of Portugal, in 
2012. The recruitment took place in consecutive MS 
consultation days, during 3 months (May to July 2012).
The population of the study was selected accord-
ing to the following inclusion criteria: age between 
35 and 45 years; diagnosis of definite MS for at least 
10 years according to the revised McDonald crite-
ria from 2005 [16]. Women with co-morbidities im-
posing additional disability, those taking chronic 
treatments with teratogenic potential and those 
who were hysterectomized were excluded from the 
study. All patients gave written informed consent 
after the approval by the Ethics Committees, Boards 
of the participating centres and National Commis-
sion for Data Protection was obtained.
A standardized questionnaire including social 
and demographic data (date of birth, marital status, 
Table I. Characteristics of the first pregnancy after MS diagnosis.
Total n
Woman’s age 29.6 ± 4.4 years 43
Intended pregnancy 88% (n = 38) 43
Pregnancy outcome
Childbirth 93% (n = 40)
43
Miscarriage 7% (n = 3)
Number of relapses before pregnancy (median) 2 (range: 0-35) 41 a
Number of relapses during pregnancy (median) 0 (range: 0-0) 42 a
Number of relapses after pregnancy (median) 0 (range: 0-2) 40 a
Women’s opposing to the attending physician  
in terms of medication use in this period
7% (n = 3) 43
Breastfeeding 72% (n = 29) 40 a
Number of relapses during breastfeeding (median) 0 (range: 0-2) 29
a Missing data for respectively two, one and three women.
Table II. Reasons given for the decrease in the number of pregnancies 
after MS diagnosis.
Total n
Fear of future disability 85% (n = 44) 52
Possibility of having relapses 38% (n = 20) 52
Other reasons 27% (n = 14) 52
Economic 29% (n = 4) 14
Medical advice 21% (n = 3) 14
Transmission to newborn 21% (n = 3) 14
Infertile husband 14% (n = 2) 14
No personal relationship 7% (n = 1) 14
Husband imposition 7% (n = 1) 14
Disability at the time of diagnosis 23% (n = 12) 52
Medication 23% (n = 12) 52
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educational level and employment status), medical 
past conditions, MS data (year of clinical onset and 
definite diagnosis, clinical form, prior and current 
treatments, number of relapses, relapses occurring 
during the pregnancies and progression of the dis-
ease) and reproductive history (intended and actu-
ally occurred pregnancies before and after MS di-
agnosis, specific pregnancies data and type of deliv-
ery) was applied to all patients.
From patients’ answers and clinical records, the 
authors retrospectively filled out electronic data-
collection forms. Data were anonymously trans-
ferred to the database to safeguard the privacy of the 
patients. 
Descriptive statistics were calculated for patient 
data (mean ± standard deviation, minimum, medi-
an, maximum for continuous variables, and percent-
ages for categorical variables). Variables were com-
pared using the Mann-Whitney and the Chi-square 
test as appropriate, and statistical significance was 
set at p < 0.05. Analysis was performed using SPSS 
software, version 15.0.
Results 
Demographics and MS history
The sample was composed by 100 women with MS, 
evenly recruited in the participating hospitals. The 
mean age was 40.0 ± 3.3 years and the mean num-
ber of school-attended-years was 12.0 ± 4.4. The 
majority of women was married (61%) and em-
ployed (52%). Mean age at the time of MS diagnosis 
was 26.3 ± 5.0 years. Ninety percent of patients pre-
sented a relapsing-remitting MS, 8% had secondary 
progressive course and 2% suffered from primary 
progressive MS. The total number of relapses the 
year before pregnancy was quite variable, with a 
median of two.
Reproductive history
At the time of MS diagnosis, 57% of women had 
never been pregnant and 28% had already had the 
intended number of children. Before MS diagnosis, 
62% of women had no children, 28% had already 
had one child, 8% had had two children and 2% had 
had three children. Fifty-seven percent of the par-
ticipants had no pregnancies after MS diagnosis, 
31% had one pregnancy, 11% had two and one per-
cent had three pregnancies. Seven percent tried to 
get pregnant and stopped the MS medication with-
out the physician’s knowledge (in most situations 
the women and the physicians discussed if the medi-
cation should be stopped or changed).
The characteristics of the first pregnancy after 
MS diagnosis are described in table I. Other preg-
nancies are not presented because no relevant dif-
ferences between them and the first pregnancy 
were observed. We perceived that 93% of the preg-
nancies were well succeeded (7% had spontaneous 
miscarriages, which is a smaller prevalence than 
that of the general population). We also found that 
during pregnancy no relapses occurred and in the 
three months post-partum most of the women were 
relapse-free. 
For the women who breastfed (72%) no additional 
co-morbidity, namely relapses, was observed dur-
ing this period.
History of motherhood decision
Seventy-seven percent of the patients (53 out of 69 
patients) reported that the number of intended 
pregnancies changed after MS diagnosis (28 women 
who had already had the intended number of preg-
nancies before diagnosis and 3 who did not answer 
were excluded from this analysis). Among these 77% 
of patients, the number of intended pregnancies de-
creased in 98% and increased in 2% (one patient). 
Concerning this matter, we decided to place these 
women in two different groups, according to their 
academic qualifications: in one group women had 
attended school less than nine years and in the other 
group women had studied more than nine years. 
There were no significant statistical differences be-
tween them (p = 0.26), both groups showing a de-
crease in the number of intended pregnancies. 
The main reasons presented for having fewer 
pregnancies than previously planned were fear of 
future disability and the possibility of having re-
lapses (Table II). 
The number of relapses, MS type and therapies 
used were not significantly different between wom-
en with or without pregnancies after MS diagnosis 
(Table III).
When asked about the impact of MS on preg-
nancy, 81% of the patients considered that MS does 
not affect pregnancy; 70% thought that it does not 
affect childbirth; 80% believed that the disease 
causes no fetal malformations. Despite the fact that 
most considered that MS has no effect on pregnan-
cy and pregnancy does not influence the disease 
course, still 43% of participants believed that preg-
nancy might worsen the disease.
Among women who got pregnant after MS diag-
nosis, 35% decided to delay the pregnancy due to 
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the disease and its possible consequences, namely 
due to fear of future disability.
Discussion
Motherhood decision in patients with MS is scarce-
ly addressed in the literature, despite the higher fre-
quency of this disease in childbearing age females. 
On the other hand, although in the last few years a 
lot of information has been gathered about MS 
pathophysiology and clinical course, patients still 
have many doubts concerning pregnancy, breast-
feeding, and their impact in the disease course.
To the best of our knowledge this is the first ob-
servational study that addresses the impact of MS 
on motherhood choice and family planning in fe-
male patients, in Europe. 
Our sample may be considered to be representa-
tive of the female Portuguese MS population, be-
cause we included MS women from different re-
gions of the country, with different levels of educa-
tion and distinct economic and marital status. We 
decided to study only female patients aged 35 to 45 
years and with at least ten years of MS diagnosis, 
taking into account that women with that age-span 
would have already had the possibility to become 
pregnant and could also have enough years of dis-
ease evolution, thus being able to have a better con-
cept of the present and future burden that the dis-
ease might have upon their lives.
Our study showed that a large percentage of 
women (77%) changed the number of intended 
pregnancies (decided to have fewer children) after 
MS diagnosis. Although not statistically significant, 
these results suggest important implications of the 
disease on motherhood decision as well as an im-
pact of diagnosis in these women life planning. 
The main reasons pointed out for having fewer 
children are the possibility of having relapses and 
fear of future disability. These results don’t fit those 
recently reported by Alwan et al who concluded 
that the most common MS-related reasons for not 
becoming pregnant are: symptoms interfering with 
parenting, fear of burdening the partner or fear of 
children inheriting MS [15]. This may be explained 
by epidemiological and cultural differences between 
Canadian and Portuguese populations. Furthermore, 
Alwan et al study lacked data on the subtypes of 
MS, disease duration and disease severity. Also, 
there was a broad spectrum of age of the patients 
included, therefore becoming a very heterogeneous 
group of study. However, both studies denoted a 
fear about the future.
Borisow et al stated that psychological factors 
should not be underestimated in family planning, 
especially in sexual contacts because factors like 
bladder or bowel dysfunction, inserted catheters, 
or fear of partner disapproval are relevant features 
that contribute to diminished sexual interest [14]. 
Although we did not study these particular issues 
we consider them to be of special importance. 
Our results are in accordance with those previ-
ously reported by Twork et al who found no differ-
ences regarding demographic data between female 
patients having children and childless MS women, 
namely in what concerns academic qualifications, 
addressed in our study [17]. However, in opposition 
to our results, Twork et al also found these women 
to be more commonly on a relationship and unem-
ployed. It has been shown that there are some dif-
ferences in living conditions, quality of life and cop-
ing behavior between mothers and childless women 
with MS, but not enough to confirm the hypothesis 
that a better quality of life and coping behavior 
would be visible in MS mothers.
Regarding MS history in the group with chil-
dren, we found that the number of pregnancies af-
Table III. Comparison of having or not having pregnancies after MS diagnosis a.
Without pregnancies  
after diagnosis (n = 37)
With pregnancies  
after diagnosis (n = 30)
p
Age (median) 40 years (range: 35-45) 38 years (range: 34-45) 0.11 b
Age at diagnosis (median) 27 years (range: 17-35) 24 years (range: 18-32) 0.05 b
Number of relapses, past year (median) 6 (range: 1-30) 5 (range: 2-20) 0.50 b
MS type
Relapsing-remitting 86.5% 96.7%
0.39 cSecondary progressive 8.1% 3.3%
Primary progressive 5.4% 0%
Therapy
Glatiramer acetate 13.5% 13.3%
0.39 c
Interferon β-1a 54.0% 46.7%
Interferon β-1b 10.8% 13.3%
Natalizumab 10.8% 16.7%
Fingolimod 5.4% 3.3%
None 5.4% 6.7%
a 28 women that already had the intended children at the time of diagnosis and 5 with not planned pregnancies 
after MS diagnosis were excluded; b Mann-Whitney test; c Chi-square test. 
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ter the diagnosis does not correlate with type of 
disease, number of relapses or immunomodulating 
therapies. Moreover, 35% of women who decided 
to get pregnant after MS diagnosis delayed this de-
cision because of the disease itself. In this popula-
tion, pregnancies and deliveries after MS diagnosis 
were devoid of complications and the majority of 
patients decided to breastfeed, in accordance to 
what is described in the literature. 
Our study revealed that patients in general have 
the knowledge that MS does not influence preg-
nancy, delivery and newborn development. These 
results are in consonance with those of Albrecht et 
al [18]. However, an important number of patients 
still believe that pregnancy is harmful to MS and 
worsens the prognosis of the disease. In fact, nowa-
days information is easily available worldwide but 
this does not mean that patients are fully aware of 
the implications of the disease or understand the 
information that is being given to them. 
Concerning breastfeeding, the main question in 
deciding whether or not to breastfeed is the fear of 
postpartum relapses that has been described to be 
higher in this period. Therefore many MS women 
decide not to breastfeed in order to initiate immu-
nomodulating therapies to avoid postpartum re-
lapses. This fact may explain why so many patients 
still believe that pregnancy worsens the disease. In 
a recent study it was concluded that exclusive 
breastfeeding, due to the consequent hormonal 
pattern that ensues, has a protective effect in de-
creasing the number of relapses [7]. However, there 
are no guidelines regarding this subject and the op-
tions should be discussed case by case.
The main limitation of our study is the possible 
memory bias, as not only a transversal but also a ret-
rospective collection of data was done. Our sample 
size limits statistical analysis, but a possible explana-
tion for that was our age-span inclusion criterion.
The present study discloses the need of a general 
effort to inform MS women in order to reduce the 
negative impact of MS diagnosis on reproductive 
issues. We believe that it is essential not to discour-
age pregnancy in these patients and to accurately 
inform them. Risks and benefits of breastfeeding 
should also be discussed with the patients, as well 
as the concern of concomitantly resuming or not 
MS therapies. We also believe that prevention of 
postpartum relapses poses a challenge for the fu-
ture: a decrease in relapse rate in this period could 
increase the confidence of MS women and encour-
age them to fulfill their desire to have a family. 
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Esclerosis múltiple y decisión de la maternidad: estudio observacional en pacientes portuguesas
Introducción. La esclerosis múltiple (EM) es una enfermedad incapacitante que afecta mayoritariamente a mujeres en 
edad fértil. La EM puede alterar el deseo de crear una familia y concebir hijos. 
Objetivo. Estudiar la influencia del diagnóstico de la EM y de su evolución sobre la decisión de ser madre. 
Pacientes y métodos. Se seleccionó una cohorte integrada por pacientes de 35-45 años diagnosticadas de EM desde hacía 
por lo menos 10 años que eran atendidas en seis centros portugueses. Las participantes respondieron a un cuestionario 
estructurado en días de consulta consecutivos. Se revisaron las historias clínicas para caracterizar y recabar información 
sobre la enfermedad y los embarazos. 
Resultados. Participaron 100 mujeres; la media de edad en el momento del diagnóstico de la EM era de 26,3 ± 5,0 años; 
el 90% de las participantes presentaba la forma remitente recurrente; el 57% de las pacientes no se habían quedado 
embarazadas después del diagnóstico. El tipo de EM y el número de recidivas no difirieron de manera significativa entre 
las mujeres que habían concebido después del diagnóstico y las que no (p = 0,39 y p = 0,50, respectivamente). El 77% no 
había tenido el número de hijos deseado. Los principales motivos aducidos fueron el temor a la incapacidad futura y la 
posibilidad de sufrir recidivas. Cuarenta y tres mujeres creían que el embarazo podía agravar la EM. 
Conclusión. En la población del estudio, la decisión de ser o no ser madre no guardó relación con el tipo de EM ni con el 
número de recidivas. No obstante, un número relevante de mujeres tuvieron menos embarazos de los que habían desea-
do antes de ser diagnosticadas y pensaban que la gestación podía empeorar la enfermedad. Sería conveniente mejorar la 
información que reciben estas pacientes a fin de minimizar el impacto del diagnóstico de la EM en la decisión de ser madre.
Palabras clave. Decisión de la maternidad. Embarazo. Embarazo planificado. Esclerosis múltiple. Portuguesas. Reproducción.
